Last reviewed · How we verify
Aicamin (orazamide)
Aicamin (generic name: orazamide) is a orazamide drug. It is currently in unknown development for Hepatic failure.
Aicamin works by interacting with cellular processes to help manage hepatic failure.
Aicamin (orazamide) is a small molecule drug in the orazamide class, developed for the treatment of hepatic failure. Its exact mechanism of action is unknown, but it is believed to work by modulating certain cellular processes. Aicamin is not FDA-approved, and its commercial status is unclear. Further research is needed to fully understand its safety and efficacy. As a result, it is not widely available or prescribed.
At a glance
| Generic name | orazamide |
|---|---|
| Drug class | orazamide |
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Imagine your liver as a factory that breaks down waste and makes energy for your body. Aicamin helps the liver factory work more efficiently, but how it does this is not yet fully understood. It may help reduce damage to liver cells or improve the way they function.
Approved indications
- Hepatic failure
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aicamin CI brief — competitive landscape report
- Aicamin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Aicamin
What is Aicamin?
How does Aicamin work?
What is Aicamin used for?
What is the generic name of Aicamin?
What drug class is Aicamin in?
What development phase is Aicamin in?
Related
- Drug class: All orazamide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Hepatic failure
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing